| Literature DB >> 23520284 |
Christopher G R Perry1, Daniel A Kane, Ian R Lanza, P Darrell Neufer.
Abstract
A growing body of research is investigating the potential contribution of mitochondrial function to the etiology of type 2 diabetes. Numerous in vitro, in situ, and in vivo methodologies are available to examine various aspects of mitochondrial function, each requiring an understanding of their principles, advantages, and limitations. This review provides investigators with a critical overview of the strengths, limitations and critical experimental parameters to consider when selecting and conducting studies on mitochondrial function. In vitro (isolated mitochondria) and in situ (permeabilized cells/tissue) approaches provide direct access to the mitochondria, allowing for study of mitochondrial bioenergetics and redox function under defined substrate conditions. Several experimental parameters must be tightly controlled, including assay media, temperature, oxygen concentration, and in the case of permeabilized skeletal muscle, the contractile state of the fibers. Recently developed technology now offers the opportunity to measure oxygen consumption in intact cultured cells. Magnetic resonance spectroscopy provides the most direct way of assessing mitochondrial function in vivo with interpretations based on specific modeling approaches. The continuing rapid evolution of these technologies offers new and exciting opportunities for deciphering the potential role of mitochondrial function in the etiology and treatment of diabetes.Entities:
Mesh:
Year: 2013 PMID: 23520284 PMCID: PMC3609570 DOI: 10.2337/db12-1219
Source DB: PubMed Journal: Diabetes ISSN: 0012-1797 Impact factor: 9.461
A comparison of the respiratory steady-state conventions
Composition of preparation and respiration buffers for assessing mitochondrial respiratory kinetics in permeabilized muscle fiber bundles (all buffers) and isolated mitochondria (MiRO5)
FIG. 1.The effect of protease inhibition or addition on contraction-mediated alterations in respiratory kinetics for ADP in Sprague-Dawley rat permeabilized red gastrocnemius fiber bundles. A and B: Michaelis-Menten–type line-fitting curves of respiratory O2 flux (JO2) in permeabilized muscle bundles, with 5 mmol/L pyruvate + 2 mmol/L malate, as a function of ADP concentration with the myosin II inhibitor blebbistatin (BLEB, 25 μmol/L), representing relaxed fibers, or vehicle (DMSO), representing contracted fibers, in two common respirometric assay media (Buffer Z [54,110,173] and Mitomed [129]). Protease inhibitors (1 μmol/L leupeptin and soybean trypsin inhibitor [STI]) were included in wash and assay buffers. C: BLEB prevented the contraction-mediated (DMSO; spontaneous contraction) increase in respiratory sensitivity to ADP (i.e., lower Kmapp) whether treated with protease inhibitors or protease (5 μmol/L trypsin, 30 min in permeabilization buffer). D: The respiratory Vmax in permeabilized muscle bundles was significantly greater with BLEB in Buffer Z only. n = 3, triplicate trials averaged. *Significantly different than BLEB, P < 0.05; **P < 0.01; ***P < 0.001.